Financhill
Back

SoftBank Group Vs. Intra-Cellular Therapies Industry Stock Comparison

Buy
55

SFTBY
SoftBank Group

Last Price:
27.29
Seasonality Move:
8.97%
Sell
28

ITCI
Intra-Cellular Therapies

Last Price:
65.55
Seasonality Move:
-6.93%
Buy
55
SoftBank Group (SFTBY) is a Buy

Is SoftBank Group a Buy, Sell or Hold?

  • The current SoftBank Group [SFTBY] share price is $27.29. The Score for SFTBY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SFTBY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $65.54. The Score for ITCI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SFTBY Stock Price Chart

What is SoftBank Group's stock price today?

  • The SoftBank Group share price today is $27.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFTBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $65.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight selling pressure.

SFTBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.17 Buy
Relative Strength Index (14 RSI): 58.1 Buy
Chaikin Money Flow: 291949 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.89 - 26.79) Buy
Bollinger Bands (100): (23.32 - 29.18) Buy

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.12 Sell
Relative Strength Index (14 RSI): 42.8 Sell
Chaikin Money Flow: -109969 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.75 - 72.21) Sell
Bollinger Bands (100): (65.8 - 71.96) Sell

SFTBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.89 Buy
20-day SMA: 26.12 Buy
50-day SMA: 27.05 Buy
200-day SMA: 23.74 Buy
8-day EMA: 26.8 Buy
20-day EMA: 26.46 Buy
50-day EMA: 26.52 Buy
200-day EMA: 24.61 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.24 Sell
20-day SMA: 67.87 Sell
50-day SMA: 68.8 Sell
200-day SMA: 62.96 Buy
8-day EMA: 66.36 Sell
20-day EMA: 67.5 Sell
50-day EMA: 68.38 Sell
200-day EMA: 64.73 Buy

SoftBank Group Earnings Growth & SFTBY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.

SoftBank Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):